Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02692716

Public ClinicalTrials.gov record NCT02692716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02692716
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
3,183 participants

Conditions and interventions

Interventions

  • semaglutide Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2017
Primary completion
Sep 24, 2018
Completion
Sep 24, 2018
Last update posted
Jul 19, 2022

2017 – 2018

United States locations

U.S. sites
71
U.S. states
24
U.S. cities
61
Facility City State ZIP Site status
Novo Nordisk Investigational Site Little Rock Arkansas 72211
Novo Nordisk Investigational Site Searcy Arkansas 72143
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Huntington Beach California 92648
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site La Mesa California 91942
Novo Nordisk Investigational Site Lancaster California 93534
Novo Nordisk Investigational Site Monterey California 93940
Novo Nordisk Investigational Site San Diego California 92111
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Ventura California 93003
Novo Nordisk Investigational Site Boca Raton Florida 33433
Novo Nordisk Investigational Site New Port Richey Florida 34652
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Savannah Georgia 31406
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Springfield Illinois 62702
Novo Nordisk Investigational Site Indianapolis Indiana 46254
Novo Nordisk Investigational Site Michigan City Indiana 46360
Novo Nordisk Investigational Site Muncie Indiana 47304
Novo Nordisk Investigational Site Council Bluffs Iowa 51501
Novo Nordisk Investigational Site Lexington Kentucky 40502
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Monroe Louisiana 71203
Novo Nordisk Investigational Site Slidell Louisiana 70461-4231
Novo Nordisk Investigational Site Canton Michigan 48187
Novo Nordisk Investigational Site Troy Michigan 48098
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Omaha Nebraska 68198
Novo Nordisk Investigational Site Las Vegas Nevada 89128
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Albany New York 12203
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site North Massapequa New York 11758-1802
Novo Nordisk Investigational Site Westfield New York 14787
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Fargo North Dakota 58104
Novo Nordisk Investigational Site Cleveland Ohio 44195
Novo Nordisk Investigational Site Columbus Ohio 43203
Novo Nordisk Investigational Site Maumee Ohio 43537
Novo Nordisk Investigational Site Beaver Pennsylvania 15009
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114
Novo Nordisk Investigational Site Anderson South Carolina 29621
Novo Nordisk Investigational Site Moncks Corner South Carolina 29461
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572
Novo Nordisk Investigational Site Spartanburg South Carolina 29303
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Knoxville Tennessee 37938
Novo Nordisk Investigational Site Nashville Tennessee 37203
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Arlington Texas 76012-4637
Novo Nordisk Investigational Site Austin Texas 78705
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Austin Texas 78749
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Hurst Texas 76054
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site Round Rock Texas 78681
Novo Nordisk Investigational Site San Antonio Texas 78220
Novo Nordisk Investigational Site San Antonio Texas 78228-6205
Novo Nordisk Investigational Site Waco Texas 76710
Novo Nordisk Investigational Site South Burlington Vermont 05403
Novo Nordisk Investigational Site Norfolk Virginia 23510-2015
Novo Nordisk Investigational Site Winchester Virginia 22601-3834

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 157 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02692716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2022 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02692716 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →